CITING PRACTICES THAT JEOPARDIZE PATIENT SAFETY, the federal Centers for Medicare & Medicaid Services decided earlier this month to revoke the CLIA certificate that it granted to Theranos Inc. to operate a clinical laboratory in Newark, Calif., and to ban the lab company’s founder and CEO Elizabeth Holmes from the operating a clinical laboratory for […]
- Lab Compliance Update
CMS CLIA Sanction Letter Sent To Theranos Raises Questions
What options are available to lab company given imposition of severe CLIA sections?
- By Joseph Burns
- > From the Volume XXIII No. 10 - July 25, 2016 Issue
